23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.30%
Revenue growth of 2.30% vs. zero growth in Insurance - Life. Walter Schloss might still want to see if it can translate into profits.
2.30%
Gross profit growth of 2.30% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that could be built upon.
7.84%
EBIT growth exceeding 1.5x Insurance - Life median of 2.86%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
7.84%
Operating income growth exceeding 1.5x Insurance - Life median of 3.50%. Joel Greenblatt would see if unique processes drive exceptional profitability.
5.36%
Net income growth of 5.36% while Insurance - Life median is zero. Walter Schloss might see potential if moderate gains can keep rising.
5.37%
EPS growth of 5.37% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
5.33%
Diluted EPS growth of 5.33% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-53.33%
Negative OCF growth while Insurance - Life median is -27.55%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-610.97%
Negative FCF growth while Insurance - Life median is -27.55%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
132.04%
10Y revenue/share CAGR 1.25-1.5x Insurance - Life median of 115.89%. Mohnish Pabrai would see if consistent reinvestment or product expansions drive this gap.
137.54%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 44.96%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
91.52%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 31.00%. Joel Greenblatt might see a short-term competitive advantage at play.
No Data
No Data available this quarter, please select a different quarter.
6439.56%
OCF/share CAGR of 6439.56% while Insurance - Life median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
42.48%
3Y OCF/share growth of 42.48% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
361.56%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 219.94% over a decade. Joel Greenblatt might see a standout compounder of earnings.
246.60%
5Y net income/share CAGR > 1.5x Insurance - Life median of 159.59%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
180.69%
3Y net income/share CAGR > 1.5x Insurance - Life median of 100.70%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
No Data
No Data available this quarter, please select a different quarter.
195.61%
5Y equity/share CAGR > 1.5x Insurance - Life median of 53.98%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
160.07%
3Y equity/share CAGR > 1.5x Insurance - Life median of 14.54%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.01%
Assets shrink while Insurance - Life median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
3.42%
BV/share growth of 3.42% while Insurance - Life is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
-52.40%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.